SCP® Observational Study of the Knee

Sponsor
Zimmer Biomet (Industry)
Overall Status
Active, not recruiting
CT.gov ID
NCT03110224
Collaborator
(none)
516
14
123.4
36.9
0.3

Study Details

Study Description

Brief Summary

Post Market clinical outcomes study to collect data on the short - and long-term outcomes for subjects who are undergoing or who have undergone the Subchondroplasty (SCP) Procedure in the knee in a standard clinical setting. Outcomes to be assessed include pain medication usage, pain, function, activity levels and patient satisfaction.

Condition or Disease Intervention/Treatment Phase
  • Device: Subchondroplasty Procedure with AccuFill

Detailed Description

This is a post-market, multi-center, patient outcomes centered study to evaluate the on-label use of AccuFill during the Subchondroplasty procedure. Enrolled subjects will sign an informed consent form, satisfy the inclusion/exclusion criteria and have at least one Bone Marrow Lesion (BML) in the knee. Demographics, medical history and medications will recorded at the time of enrollment. Surgical details including the SCP procedure, concomitant surgical procedures and intraoperative safety events will be recorded. Subjects will complete patient reported outcomes measures pre-operatively including the Visual Analog Scale (VAS) for knee pain, International Knee Documentation Committee Subject Knee (IKDC) Form and the Veterans Rand 12 (VR-12) Item Health Survey. These measures will also be administered post-operatively at 6 weeks, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, and 5 years. Screening for adverse events and revision surgeries will occur throughout the study.

Target enrollment is 1000 subjects at up to 30 clinical sites. Subjects will complete the study at 5 years or will be withdrawn if the patient undergoes revision surgery of the Subchondroplasty site.

Study Design

Study Type:
Observational [Patient Registry]
Actual Enrollment :
516 participants
Observational Model:
Cohort
Time Perspective:
Other
Official Title:
Zimmer Knee Creations SCP® Observational Cohort Follow-Up Study
Actual Study Start Date :
Sep 18, 2012
Actual Primary Completion Date :
Sep 16, 2020
Anticipated Study Completion Date :
Dec 31, 2022

Outcome Measures

Primary Outcome Measures

  1. Change from baseline Visual Analog Scale (VAS) Pain Scale at 12 months [12 months]

    Change from baseline score of pain intensity at 12 months.

Secondary Outcome Measures

  1. Incidence and severity of device and/or procedure related adverse events and re-visions/re-operations [5 years]

    Summary and description of procedure and device related adverse events and surgical re-operations and relatedness to the bone substitute material and procedure

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Surgeon considers patient appropriate for SCP procedure.

  2. Patient has agreed to undergo the SCP procedure or has already undergone the procedure.

  3. Subject is willing and able to sign a written consent form.

  4. The subject has the mental capacity and the willingness to contribute follow-up outcome data.

  5. Patient is willing and able to complete outcome forms in person or by phone, email or regular mail.

Exclusion Criteria:
  1. Patient is not comfortable with speaking, reading, and understanding questions and providing responses in an available language for the PROs in the protocol.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Denver-Vail Orthopedics Parker Colorado United States 80134
2 Atlantis Orthopaedics Palm Beach Gardens Florida United States 33410
3 Foundation for Orthopaedic Research and Education (FORE) Tampa Florida United States 33637
4 Southern Ortho Johns Creek Georgia United States 30097
5 OrthoIndy Indianapolis Indiana United States 46143
6 Cascio Sports Medicine Lake Charles Louisiana United States 70601
7 Brigham and Women's Hospital Boston Massachusetts United States 02115
8 Orthopaedic Surgical Associates North Chelmsford Massachusetts United States 01863
9 Beaumont Health System Royal Oak Michigan United States 48073
10 Associated Orthopedists Saint Clair Shores Michigan United States 48080
11 New York University School of Medicine Huntington Station New York United States 11746
12 Ohio State University Columbus Ohio United States 43221
13 Allegheny Singer Research Institute Pittsburgh Pennsylvania United States 15212
14 Jordan-Young Institute Virginia Beach Virginia United States 23462

Sponsors and Collaborators

  • Zimmer Biomet

Investigators

  • Study Director: Charles Jaggard, Zimmer Biomet

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Zimmer Biomet
ClinicalTrials.gov Identifier:
NCT03110224
Other Study ID Numbers:
  • KC.CR.I.AM.16.3
First Posted:
Apr 12, 2017
Last Update Posted:
Oct 12, 2021
Last Verified:
Oct 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Keywords provided by Zimmer Biomet

Study Results

No Results Posted as of Oct 12, 2021